Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ankyrin repeat domain 30A pseudogene (ENSG00000215512) is a non-functional DNA segment in the human genome derived from the ANKRD30A gene. It does not encode a protein and is not expressed under normal conditions. Pseudogenes like this one arise either from duplication or retrotransposition events and typically have disabling mutations. While the parent gene "ankyrin repeat domain 30A (ANKRD30A)" is a protein-coding gene with potential disease implications, the pseudogene itself has no direct biological function, clinical relevance, or utility as a pharmacological target.\n\nIn summary, this entry represents a pseudogene, not a protein-coding gene and should not be considered a therapeutic target. If you intended to reference the druggable, functional gene, consider "Ankyrin repeat domain 30A (ANKRD30A)" instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 30A pseudogene.